Inventor · disambiguated record
Thomas Miller
Also filed as: DIECKHAUS CHRISTINE M · MILLER THOMAS · MILLER THOMAS A · MILLER THOMAS ALLEN
34 granted patents·13 pending applications·287 citations·filing 2001–2023
97Inventor score
Files withMERCK SHARP & DOHME14TAKEDA PHARMACEUTICALS CO5MERCK & CO INC3CERTA THERAPEUTICS PTY LTD2GRIMM JONATHAN2
Top patents by PatentIndex Score
47 records- 0193US11352356B2Inhibitors of plasma kallikrein and uses thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Jun 7, 2022·4 cites·29 claims
- 0293US7981874B2Phosphorus derivatives as histone deacetylase inhibitorsMERCK SHARP & DOHME·Filed 2007·Granted Jul 19, 2011·21 cites·17 claims
- 0393US7544695B2Spirocyclic compoundsMERCK & CO INC·Filed 2006·Granted Jun 9, 2009·29 cites·14 claims
- 0492US10730874B2Inhibitors of plasma kallikrein and uses thereofSHIRE HUMAN GENETIC THERAPIES·Filed 2019·Granted Aug 4, 2020·7 cites·18 claims
- 0592US6538024B1Felbamate derived compoundsUNIV VIRGINIA·Filed 2001·Granted Mar 25, 2003·52 cites·15 claims
- 0691US8686020B2Spirocyclic compoundsMERCK SHARP & DOHME·Filed 2012·Granted Apr 1, 2014·17 cites·6 claims
- 0791US8349825B2Spirocyclic compoundsMERCK SHARP & DOHME·Filed 2010·Granted Jan 8, 2013·18 cites·6 claims
- 0890US8026260B2Histone deacetylase inhibitors with aryl-pyrazolyl-motifsMERCK SHARP & DOHME·Filed 2006·Granted Sep 27, 2011·9 cites·15 claims
- 0990US7834026B2Spirocyclic compoundsMERCK SHARP & DOHME·Filed 2006·Granted Nov 16, 2010·17 cites·6 claims
- 1089US7507858B2Histone deacetylase inhibitorsMERCK & CO INC·Filed 2005·Granted Mar 24, 2009·13 cites·11 claims
- 1186US8796310B2Amino-pyridine-containing spleen tyrosine kinase (SYK) inhibitorsROMEO ERIC THOMAS·Filed 2012·Granted Aug 5, 2014·16 cites·38 claims
- 1286US8119685B2Disubstituted aniline compoundsHEIDEBRECHT RICHARD·Filed 2007·Granted Feb 21, 2012·18 cites·10 claims
- 1385US8461189B2Pyridyl derivatives as histone deacetylase inhibitorsHEIDEBRECHT JR RICHARD W·Filed 2008·Granted Jun 11, 2013·15 cites·19 claims
- 1485US7834034B2Benzothiophene derivativesMERCK SHARP & DOHME·Filed 2006·Granted Nov 16, 2010·9 cites·11 claims
- 1581US8389553B24-carboxybenzylamino derivatives as histone deacetylase inhibitorsHARRINGTON PAUL·Filed 2008·Granted Mar 5, 2013·5 cites·2 claims
- 1680US2024199602A1Inhibitors of plasma kallikrein and uses thereofTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 1779US11168083B2Inhibitors of Plasma Kallikrein and uses thereofTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Nov 9, 2021·1 cites·20 claims
- 1879US9096559B24-carboxybenzylamino derivatives as histone deacetylase inhibitorsHARRINGTON PAUL·Filed 2013·Granted Aug 4, 2015·5 cites·3 claims
- 1979US8158825B2Modified malonate derivativesGRIMM JONATHAN·Filed 2006·Granted Apr 17, 2012·9 cites·17 claims
- 2077US7795304B2Histone deacetylase inhibitorsMERCK SHARP & DOHME·Filed 2005·Granted Sep 14, 2010·3 cites·13 claims
- 2177US7772238B2Benzothiophene hydroxamic acid derivativesMERCK SHARP & DOHME·Filed 2006·Granted Aug 10, 2010·4 cites·15 claims
- 2277US7737184B2Histone deacetylase inhibitorsMERCK SHARP & DOHME·Filed 2005·Granted Jun 15, 2010·3 cites·15 claims
- 2376US11014873B2Anti-fibrotic compoundsCERTA THERAPEUTICS PTY LTD·Filed 2018·Granted May 25, 2021·1 cites·16 claims
- 2474US6759402B2Cyclic felbamate derived compoundsUNIV VIRGINIA·Filed 2003·Granted Jul 6, 2004·6 cites·30 claims
- 2573US11905285B2Inhibitors of plasma kallikrein and uses thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Feb 20, 2024·0 cites·20 claims
- 2671US12441724B2Inhibitors of plasma kallikrein and uses thereofTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Oct 14, 2025·0 cites·29 claims
- 2771US8119652B2Aryl-fused spirocyclic compoundsHAMBLETT CHRISTOPHER·Filed 2007·Granted Feb 21, 2012·3 cites·6 claims
- 2869US11603349B2Anti-fibrotic compoundsCERTA THERAPEUTICS PTY LTD·Filed 2021·Granted Mar 14, 2023·0 cites·16 claims
- 2967US8168658B2Inhibitors of histone deacetylaseGRIMM JONATHAN B·Filed 2007·Granted May 1, 2012·2 cites·7 claims
- 3057US2022296616A1Shp1 and shp2 inhibitors and their methods of useTIAKI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3153US2015284381A1Amino-pyridine-containing spleen tyrosine kinase (syk) inhibitorsMERCK SHARP & DOHME·Filed 2013·Application pending·0 cites
- 3252US2014323440A1Amino-pyridine-containing spleen tyrosine kinase (syk) inhibitorsMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 3351US9745295B2Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Aug 29, 2017·0 cites·10 claims
- 3450US2012142770A1Pharmaceutical compositions of hdac inhibitors and chelatable metal compounds, and metal-hdac inhibitor chelate complexesMCKEOWN ARLENE E·Filed 2011·Application pending·0 cites
- 3550US2009156825A1Fluorescent compounds that bind to histone deacetylaseHEIDEBRECHT JR RICHARD W·Filed 2008·Application pending·0 cites
- 3650US2009239946A1Pharmaceutical compositions of HDAC inhibitors and chelatable metal compounds, and metal-HDAC inhibitors chelate complexesMCKEOWN ARLENE E·Filed 2007·Application pending·0 cites
- 3749US2020316178A1Formulations comprising glucocerebrosidase and isofagomineSHIRE HUMAN GENETIC THERAPIES·Filed 2018·Application pending·0 cites
- 3846US9670196B2Thiazole-substituted aminoheteroaryls as Spleen Tyrosine Kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Jun 6, 2017·0 cites·15 claims
- 3945US7872024B2Benzothiophene hydroxamic acid derivatives with carbamate, urea, amide and sulfonamide substitutionsMERCK SHARP & DOHME·Filed 2006·Granted Jan 18, 2011·0 cites·17 claims
- 4045US2010216796A1N-hydroxy-naphthalene dicarboxamide and n-hydroxy-biphenyl-dicarboxamide compounds as histone deacetylase inhibitorsKATTAR SOLOMON·Filed 2008·Application pending·0 cites
- 4144US2009012075A1Fluorinated Arylamide DerivativesMILLER THOMAS A·Filed 2007·Application pending·0 cites
- 4244US2011130361A1Silicon derivatives as histone deacetylase inhibitorsGRIMM JONATHAN·Filed 2008·Application pending·0 cites
- 4343US7534918B2Histone deacetylase inhibitorsMERCK & CO INC·Filed 2005·Granted May 19, 2009·0 cites·17 claims
- 4438US2009105264A1Substituted Nicotinamide CompoundsHAMBLETT CHRISTOPHER·Filed 2006·Application pending·0 cites
- 4538US2009062297A1Hydroxyalkylarylamide DerivativesHEIDEBRECHT RICHARD W·Filed 2007·Application pending·0 cites
- 4636US8609897B2Trifluoromethylsulfonamide gamma secretase inhibitorDANIELS MATTHEW·Filed 2010·Granted Dec 17, 2013·0 cites·8 claims
- 4730US8871796B2Diaryl ether derivatives as notch sparing gamma secretase inhibitorsBROWN WILLIAM COLBY·Filed 2010·Granted Oct 28, 2014·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Thomas Miller files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →